Company or ticker...

Palvella Therapeutics

Palvella develops treatments for rare genetic skin diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PVLA

2.1B

0.0

n/a

42.61%

Key Facts

M. Cap

PS

PE

YTD

2.1B

0.0

n/a

42.61%

10MA

20MA

50MA

200MA

$PVLA